Juan Carlos Q Vélez, MD
@juancarlosqvelez.bsky.social
🩺 Academic Nephrologist, Ochsner Health, New Orleans, LA, USA
🎓Professor of Medicine, Ochsner Clinical School - The University of Queensland, QLD, Australia
🔬Self-proclaimed Pisse Prophet
🎓Professor of Medicine, Ochsner Clinical School - The University of Queensland, QLD, Australia
🔬Self-proclaimed Pisse Prophet
Reposted by Juan Carlos Q Vélez, MD
Points acknowledged but the graph allows one to see the relative changes and the shape of things that came/to come. The losartan curve is our progress vs placebo, while the others show the progress against losartan. Overall one may expect an effect similar to losartan under single agent adoption
December 1, 2025 at 2:04 AM
Points acknowledged but the graph allows one to see the relative changes and the shape of things that came/to come. The losartan curve is our progress vs placebo, while the others show the progress against losartan. Overall one may expect an effect similar to losartan under single agent adoption
Oh I’m interested. Clever and fancy. But the question is how quickly it’ll become clinically available. I suppose it’ll need further validation here in North America
November 29, 2025 at 2:06 AM
Oh I’m interested. Clever and fancy. But the question is how quickly it’ll become clinically available. I suppose it’ll need further validation here in North America
Trying to pronounce the brand name
a man with red curly hair and glasses is wearing a suit and tie and making a funny face .
ALT: a man with red curly hair and glasses is wearing a suit and tie and making a funny face .
media.tenor.com
November 26, 2025 at 1:38 AM
Trying to pronounce the brand name
Reposted by Juan Carlos Q Vélez, MD
even in their 2024 guidelines they downgrade the level of evidence for resistant hypertension.
Yes, spiro causes hyperK but that is easily managed with diuretics, especially in CKD.
Yes, spiro causes hyperK but that is easily managed with diuretics, especially in CKD.
November 23, 2025 at 4:08 PM
even in their 2024 guidelines they downgrade the level of evidence for resistant hypertension.
Yes, spiro causes hyperK but that is easily managed with diuretics, especially in CKD.
Yes, spiro causes hyperK but that is easily managed with diuretics, especially in CKD.
13. To close, it was a remarkable experience. I discovered a microcosmos of talented and enthusiast professionals from other parts of the world who are eager to learn and ultimately improve the way they report their findings in order to help clinicians better use the information to treat patients
November 21, 2025 at 5:24 PM
13. To close, it was a remarkable experience. I discovered a microcosmos of talented and enthusiast professionals from other parts of the world who are eager to learn and ultimately improve the way they report their findings in order to help clinicians better use the information to treat patients
12. New stain. Carlos generously brought me a new stain for my lab: the Sternheimer (S) stain, not to be confused with the Sternheimer-Malbin (SM) stain. Within a distinct color pattern, the S stain offers better visualization of nuclei (blue) respect to cytoplasm (red). I’m already enjoying it
November 21, 2025 at 5:24 PM
12. New stain. Carlos generously brought me a new stain for my lab: the Sternheimer (S) stain, not to be confused with the Sternheimer-Malbin (SM) stain. Within a distinct color pattern, the S stain offers better visualization of nuclei (blue) respect to cytoplasm (red). I’m already enjoying it
11. Another highlight was to meet (Ana Paula Franz and Carlos Martinez-F) for the first time 2 of our coauthors of our transcontinental collaboration to describe for the first time the clinical phenotype associated with vacuolar casts in the #UrinarySediment pdfs.journals.lww.com/kidney360/20...
November 21, 2025 at 5:24 PM
11. Another highlight was to meet (Ana Paula Franz and Carlos Martinez-F) for the first time 2 of our coauthors of our transcontinental collaboration to describe for the first time the clinical phenotype associated with vacuolar casts in the #UrinarySediment pdfs.journals.lww.com/kidney360/20...
10. Education. As I mentioned, I learned a lot during the 3 days. Here is just a snapshot of that. Presentations by Dr Fogazzi on spheroplasts and by MT Fiorella Anguilleri on Fabry mulberry bodies
November 21, 2025 at 5:24 PM
10. Education. As I mentioned, I learned a lot during the 3 days. Here is just a snapshot of that. Presentations by Dr Fogazzi on spheroplasts and by MT Fiorella Anguilleri on Fabry mulberry bodies
9. High volume labs continue to depend on automated analyzers. It was great to see that this industry is thriving. I expect major advances with the rise of AI. But it comes down to quality of image acquisition. AI can only be as good as the info fed into it
November 21, 2025 at 5:24 PM
9. High volume labs continue to depend on automated analyzers. It was great to see that this industry is thriving. I expect major advances with the rise of AI. But it comes down to quality of image acquisition. AI can only be as good as the info fed into it
8. Collaborative mindset. In LatinAmerica, lab professionals in charge of urinalysis earn various degrees: Medical Technologists, Chemists/Biologists, etc.; very talented people genuinely interested in learning from clinicians, as much as I am in learning from them. Something to learn 4 us here in 🇺🇸
November 21, 2025 at 5:24 PM
8. Collaborative mindset. In LatinAmerica, lab professionals in charge of urinalysis earn various degrees: Medical Technologists, Chemists/Biologists, etc.; very talented people genuinely interested in learning from clinicians, as much as I am in learning from them. Something to learn 4 us here in 🇺🇸